{"id":"W3040330927","doi":"10.1016/j.medj.2020.05.003","title":"Life and limb protection with dual anti-thrombotic pathway inhibition: COMPASS ushers in a new day in atherothrombotic risk reduction","year":2020,"lang":"en","type":"review","venue":"Med","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"Oakville-Trafalgar Memorial Hospital; St Joseph's Health Centre; Thrombosis and Atherosclerosis Research Institute; McMaster University; Population Health Research Institute; University of Toronto; St. Michael's Hospital","funders":"Janssen Pharmaceuticals; Duke Clinical Research Institute; St. Jude Medical; Cardiological Society of India; Defence Science Institute; Ferring Pharmaceuticals; Belvoir Media Group; Novo Nordisk; Daiichi-Sankyo; Medicines Company; Boston Scientific Corporation; Merck; Mayo Clinic; Bayer; Abbott Laboratories; CSL Behring; Cleveland Clinic; Bristol-Myers Squibb; Eli Lilly and Company; Biotronik; AstraZeneca; Pfizer; Icahn School of Medicine at Mount Sinai; Takeda Pharmaceutical Company; American College of Cardiology Foundation; Boehringer Ingelheim; Amgen","keywords":"Dual (grammatical number); Reduction (mathematics); Medicine; Compass; Pharmacology; Internal medicine; Art","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001371926,0.001038992,0.003598439,0.001541963,0.0003078602,0.001836583,0.001204835,0.00191537,0.00845977],"category_scores_gemma":[0.001623782,0.0003271358,0.001315457,0.00178217,0.0005655597,0.001761118,0.000920432,0.003747006,0.002238528],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005781697,"about_ca_system_score_gemma":0.001375029,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009283234,"about_ca_topic_score_gemma":0.003711895,"domain_scores_codex":[0.9996417,0.00009586441,0.00006305682,0.00005697936,0.0001034715,0.00003904303],"domain_scores_gemma":[0.9992039,0.0004735732,0.0001243018,0.00001584508,0.0001267111,0.00005560292],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004311635,0.0001163249,0.000137635,0.0369757,0.0005394378,0.000109338,0.00004403554,0.0001866106,0.0007544798,0.002966105,0.05935415,0.8983851],"study_design_scores_gemma":[0.0005119912,0.0006211563,0.00149907,0.02432763,0.001803485,0.0007530139,0.00009879541,0.0002592147,0.0002479693,0.003415373,0.9664057,0.0000564809],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000531335,0.9987533,0.00005389822,0.0004613051,0.0003152374,0.000003638194,0.0000202112,0.000005500151,0.0003337064],"genre_scores_gemma":[0.000470445,0.9976727,0.0001353897,0.001005563,0.0004207834,0.000006357358,0.0000288226,0.000001577076,0.0002584362],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00845977,"threshold_uncertainty_score":0.02830076,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03687716629519933,"score_gpt":0.2659535901402745,"score_spread":0.2290764238450752,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}